---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-22-042550"
form_type: "8-K"
ticker: "TMO"
cik: "0000097745"
company_name: "THERMO FISHER SCIENTIFIC INC."
filed_at: "2022-11-21T23:59:59+00:00"
generated_at: "2026-06-21T15:32:32.544480+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Thermo Fisher issues €1.25B in 3.200%/3.650% notes due 2026/2034 and $1.2B in 4.800%/4.950% notes due 2027/2032

## Summary
- Euro offering: €500M 3.200% notes due 2026 and €750M 3.650% notes due 2034; net proceeds ~€1.24B.
- USD offering: $600M 4.800% notes due 2027 and $600M 4.950% notes due 2032; net proceeds ~$1.19B.
- Proceeds for general corporate purposes, including acquisitions, debt repayment, share repurchases.
- Entered into $1.2B Japanese yen cross currency swaps upon closing of USD offering.

## SEC filing metadata
- accession: 0001140361-22-042550
- form_type: 8-K
- ticker: TMO
- cik: 0000097745
- company_name: THERMO FISHER SCIENTIFIC INC.
- filed_at: 2022-11-21T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/97745/000114036122042550/0001140361-22-042550-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/97745/000114036122042550/ny20005859x7_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-22-042550
- JSON: https://secwatch.observer/filing/0001140361-22-042550.json
- Plain text: https://secwatch.observer/filing/0001140361-22-042550.txt

## Key facts
- Material Agreements
  THERMO FISHER SCIENTIFIC INC. entered into Twenty-Sixth Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. valued at $600,000,000 and $600,000,000 (effective 2022-11-21).
  - Action: entry
  - Agreement: notes offering
  - Counterparty: The Bank of New York Mellon Trust Company, N.A.
  - Value: $600,000,000 and $600,000,000
  - Effective: 2022-11-21
  source text: USD Offering On November 21, 2022, the Company issued $600,000,000 aggregate principal amount of 4.800% Senior Notes due 2027 (the “2027 Notes”) and $600,000,000 aggregate principal amount of 4.950% Senior Notes due 2032 (the “2032 Notes” and, together with the 2027 Notes, the “USD Notes”) in a public offering (the “USD Offering”) pursuant to a registration statement on Form S-3 (File No. 333-263034) and a preliminary prospectus supplement and prospectus supplement related to the offering of the USD Notes, each as previously filed with the SEC. The USD Notes were issued under the Base Indenture and the Twenty-Sixth Supplemental Indenture, dated as of November 21, 2022 (the “USD Supplemental Indenture” and, together with the Base Indenture, the “USD Indenture”), between the Company and the Trustee.
  evidence_url: https://www.sec.gov/Archives/edgar/data/97745/000114036122042550/0001140361-22-042550-index.htm
- Material Agreements
  THERMO FISHER SCIENTIFIC INC. entered into Twenty-Fifth Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. valued at €500,000,000 and €750,000,000 (effective 2022-11-21).
  - Action: entry
  - Agreement: notes offering
  - Counterparty: The Bank of New York Mellon Trust Company, N.A.
  - Value: €500,000,000 and €750,000,000
  - Effective: 2022-11-21
  source text: On November 21, 2022, Thermo Fisher Scientific Inc. (the “Company”) issued €500,000,000 aggregate principal amount of 3.200% Senior Notes due 2026 (the “2026 Notes”) and €750,000,000 aggregate principal amount of 3.650% Senior Notes due 2034 (the “2034 Notes”, and, together with the 2026 Notes, the “Euro Notes”) in a public offering (the “Euro Offering”) pursuant to a registration statement on Form S-3 (File No. 333-263034) and a preliminary prospectus supplement and prospectus supplement related to the offering of the Euro Notes, each as previously filed with the Securities and Exchange Commission (the “SEC”). The Euro Notes were issued under an indenture, dated as of November 20, 2009 (the “Base Indenture”), and the Twenty-Fifth Supplemental Indenture, dated as of November 21, 2022 (the “Euro Supplemental Indenture” and, together with the Base Indenture, the “Euro Indenture”), between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Truste
  evidence_url: https://www.sec.gov/Archives/edgar/data/97745/000114036122042550/0001140361-22-042550-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.